BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16817012)

  • 1. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.
    To-Figueras J; Badenas C; Carrera C; Muñoz C; Milá M; Lecha M; Herrero C
    J Inherit Metab Dis; 2006 Aug; 29(4):580-5. PubMed ID: 16817012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
    Kauppinen R; von und zu Fraunberg M
    Clin Chem; 2002 Nov; 48(11):1891-900. PubMed ID: 12406973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).
    Solis C; Lopez-Echaniz I; Sefarty-Graneda D; Astrin KH; Desnick RJ
    Mol Med; 1999 Oct; 5(10):664-71. PubMed ID: 10602775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study.
    Andersson C; Floderus Y; Wikberg A; Lithner F
    Scand J Clin Lab Invest; 2000 Nov; 60(7):643-8. PubMed ID: 11202057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.
    Nordmann Y; Puy H; Da Silva V; Simonin S; Robreau AM; Bonaiti C; Phung LN; Deybach JC
    J Intern Med; 1997 Sep; 242(3):213-7. PubMed ID: 9350165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.
    Paradisi I; Arias S
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S455-63. PubMed ID: 20978940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
    De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
    Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria.
    Fraunberg MVUZ; Pischik E; Udd L; Kauppinen R
    Medicine (Baltimore); 2005 Jan; 84(1):35-47. PubMed ID: 15643298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
    Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
    Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
    Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
    Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An odd case of heteroallelic acute intermittent porphyria in the Argentinean population.
    Piñeiro Pauwels MB; Gerez EN; Martinez MC; Melito VA; Parera VE; Batlle A; Rossetti MV
    Cell Mol Biol (Noisy-le-grand); 2013 Mar; 59 Suppl():OL1855-60. PubMed ID: 23522335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian "foreign Protestant" population with acute intermittent porphyria: a founder effect.
    Greene-Davis ST; Neumann PE; Mann OE; Moss MA; Schreiber WE; Welch JP; Langley GR; Sangalang VE; Dempsey GI; Nassar BA
    Clin Biochem; 1997 Dec; 30(8):607-12. PubMed ID: 9455613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
    Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
    Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of porphobilinogen (PBG) deaminase gene mutations in acute intermittent porphyria: first study in patients of Slavic origin.
    Rosipal R; Puy H; Lamoril J; Martasek P; Nordmann Y; Deybach JC
    Scand J Clin Lab Invest; 1997 May; 57(3):217-24. PubMed ID: 9238757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an ancestral founder of the common R116W mutation in the hydroxymethylbilane synthase gene in acute intermittent porphyria in The Netherlands.
    de Rooij FW; Kavelaars FG; Koole-Lesuis H; Wilson JH
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):64-9. PubMed ID: 19656453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.
    Chen CH; Astrin KH; Lee G; Anderson KE; Desnick RJ
    J Clin Invest; 1994 Nov; 94(5):1927-37. PubMed ID: 7962538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
    Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.
    Barreda-Sánchez M; Buendía-Martínez J; Glover-López G; Carazo-Díaz C; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Rodriguez-Peña L; Serrano-Antón AT; Gil-Ferrer R; Martínez-Romero MDC; Carbonell-Meseguer P; Guillén-Navarro E
    Orphanet J Rare Dis; 2019 Feb; 14(1):59. PubMed ID: 30808393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxymethylbilane synthase gene mutations and polymorphisms in Brazilian families with acute intermittent porphyria.
    Gonzaga AD; de Amorim LM; Fonseca AB; Nogueira TL; Pereira OM; Nagai MA; de Oliveira Barretto OC; Ribeiro GS
    Ann Hum Genet; 2015 May; 79(3):162-72. PubMed ID: 25703257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.